Providing solutions for the medical device and pharmaceutical industries, it will continue operating with Nelipak Healthcare Packaging as its name.
Nelipak president and CEO Mike Kelly said: “We have accomplished a lot at Nelipak during the past six years and we are very grateful for the support given to us by Mason Wells. Our future is very bright with Kohlberg.
“Kohlberg is committed to investing in Nelipak to make us an even stronger organisation, with additional capabilities to offer our customers around the world.
“With our global locations, world-class design team, modern cleanroom manufacturing, strong sales organisation and experienced management team, Nelipak is well-positioned to take advantage of growth opportunities in the market.”
Nelipak produces custom-designed rigid healthcare packaging used for Class II and Class III medical devices, as well as pharmaceutical drug delivery products.
The packaging firm also offers medical trays and blisters, as well as trays for surgical procedures and pharmaceutical handling, custom-built sealing machines, and other value-added services.
Headquartered in Cranston, Rhode Island, the company operates seven production facilities, consisting of five in the US and one in each of the Netherlands and the Republic of Ireland. It currently employs more than 800 people around the world.
Commenting on the future of the packaging firm, Kohlberg operating partner Roger Prevot said: “Our plans include leveraging Mike and his team, and their customer relationships, with sizeable, global acquisitions.
“A business with Nelipak’s global market position represents a unique investment opportunity. We look forward to supporting Mike and his team as they continue to execute their plan for organic and M&A-driven growth, while continuing to provide their customers with best-in-class service.”